I don't know whether or not I am right or wrong but hasn't the FDA put limits on what CYDY can do to increase exposure about a drug that is still in clinical stages? I sure don't want to put a damper on anyone that wants the world to know about Lironlimab, ( I sure would love it), but aren't there some restraints that our company has to adhere to about blanketing the internet about all the possibilities and indications that our drug can help with:?

Just questioning it all and don't want to put any pressure on the FDA cause they could slow down the approval processes, just saying and wondering that's all - GLTU DCiddy and all longs

HCIT